{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:00Z","timestamp":1787021220620,"version":"build-2736575974"},"reference-count":26,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"National Institute for Health Research Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Addenbrooke\u2019s Charitable Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent hypoglycemia is common in the newborn and is associated with poor neurodevelopmental outcome. Adequate monitoring is critical in prevention, but is dependent on frequent, often hourly blood sampling. Continuous glucose monitoring (CGM) is increasingly being used in children with type 1 diabetes mellitus, but use in neonatology remains limited. We aimed to introduce real-time CGM to provide insights into patterns of dysglycemia and to support the management of persistent neonatal hypoglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single-center retrospective study of real-time CGM use over a 4-year period in babies with persistent hypoglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CGMs were inserted in 14 babies: 8 term and 6 preterm infants, 9 with evidence of congenital hyperinsulinism (CHI). A total of 224 days of data was collected demonstrating marked fluctuations in glucose levels in babies with CHI, with a higher sensor glucose SD (1.52\u2005\u00b1\u20050.79 mmol\/L vs 0.77\u2005\u00b1\u20050.22 mmol\/L) in infants with CHI compared with preterm infants. A total of 1254 paired glucose values (CGM and blood) were compared and gave a mean absolute relative difference of 11%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CGM highlighted the challenges of preventing hypoglycemia in these babies when using intermittent blood glucose levels alone, and the potential application of CGM as an adjunct to clinical care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgab601","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T13:35:35Z","timestamp":1629293735000},"page":"e246-e253","source":"Crossref","is-referenced-by-count":27,"title":["Continuous Glucose Monitoring in the Management of Neonates With Persistent Hypoglycemia and Congenital Hyperinsulinism"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-9825","authenticated-orcid":false,"given":"Myat","family":"Win","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Beckett","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Thomson","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Thankamony","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK"},{"name":"Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-183X","authenticated-orcid":false,"given":"Kathryn","family":"Beardsall","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK"},{"name":"Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"issue":"2","key":"2022021012531910300_CIT0001","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MOP.0000000000000319","article-title":"Neonatal hypoglycemia","volume":"28","author":"Adamkin","year":"2016","journal-title":"Curr Opin Pediatr."},{"issue":"3","key":"2022021012531910300_CIT0002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1542\/peds.107.3.476","article-title":"Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia","volume":"107","author":"Menni","year":"2001","journal-title":"Pediatrics."},{"key":"2022021012531910300_CIT0003","author":"Laura","year":"2015"},{"issue":"1","key":"2022021012531910300_CIT0004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-018-0867-6","article-title":"The burden of congenital hyperinsulinism in the United Kingdom: a cost of illness study","volume":"13","author":"Eljamel","year":"2018","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"2022021012531910300_CIT0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/dme.13823","article-title":"Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia","volume":"36","author":"Banerjee","year":"2019","journal-title":"Diabet Med."},{"issue":"S3","key":"2022021012531910300_CIT0006","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/dia.2017.0035","article-title":"Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes","volume":"19","author":"Rodbard","year":"2017","journal-title":"Diabetes Technol Ther."},{"key":"2022021012531910300_CIT0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40748-017-0055-z","article-title":"Continuous glucose monitoring in neonates: a review","volume":"3","author":"McKinlay","year":"2017","journal-title":"Matern Health Neonatol Perinatol."},{"issue":"1","key":"2022021012531910300_CIT0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/dia.2018.0221","article-title":"A feasibility study of paired continuous glucose monitoring intrapartum and in the newborn in pregnancies complicated by type 1 diabetes","volume":"21","author":"Stewart","year":"2019","journal-title":"Diabetes Technol Ther."},{"issue":"5","key":"2022021012531910300_CIT0009","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000506230","article-title":"Continuous glucose monitoring systems: are they useful for evaluating glycemic control in children with hyperinsulinism?","volume":"92","author":"Rayannavar","year":"2019","journal-title":"Horm Res Paediatr."},{"issue":"12","key":"2022021012531910300_CIT0010","doi-asserted-by":"crossref","first-page":"e21770","DOI":"10.2196\/21770","article-title":"Open-source technology for real-time continuous glucose monitoring in the neonatal intensive care unit: case study in a neonate with transient congenital hyperinsulinism","volume":"22","author":"Braune","year":"2020","journal-title":"J Med Internet Res."},{"key":"2022021012531910300_CIT0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13633-018-0057-2","article-title":"Continuous flash glucose monitoring in children with congenital hyperinsulinism; first report on accuracy and patient experience","volume":"2018","author":"Alsaffar","year":"2018","journal-title":"Int J Pediatr Endocrinol."},{"issue":"2","key":"2022021012531910300_CIT0012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","article-title":"Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children","volume":"167","author":"Thornton","year":"2015","journal-title":"J Pediatr."},{"key":"2022021012531910300_CIT0013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2022021012531910300_CIT0014","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MOP.0000000000000592","article-title":"Neonatal hypoglycemia: continuous glucose monitoring","volume":"30","author":"Shah","year":"2018","journal-title":"Curr Opin Pediatr."},{"key":"2022021012531910300_CIT0015","volume-title":"J Endocr Soc"},{"issue":"1","key":"2022021012531910300_CIT0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1932296816662047","article-title":"Significance and reliability of MARD for the accuracy of CGM systems","volume":"11","author":"Reiterer","year":"2017","journal-title":"J Diabetes Sci Technol."},{"key":"2022021012531910300_CIT0017","article-title":"Evaluating clinical accuracy of systems for self-monitoring of blood glucose","volume-title":"Diabetes Care","author":"Clarke"},{"issue":"3","key":"2022021012531910300_CIT0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1479164118756240","article-title":"Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice","volume":"15","author":"Ajjan","year":"2018","journal-title":"Diab Vasc Dis Res."},{"key":"2022021012531910300_CIT0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2020.02.079","article-title":"Glucose profiles in healthy term infants in the first 5 days: the glucose in well babies (GLOW) study","volume":"223","author":"Harris","year":"2020","journal-title":"J Pediatr."},{"issue":"8","key":"2022021012531910300_CIT0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"issue":"1","key":"2022021012531910300_CIT0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2012.05.007","article-title":"Interstitial fluid glucose time-lag correction for real-time continuous glucose monitoring","volume":"8","author":"Barry Keenan","year":"2013","journal-title":"Biomed Signal Process Control"},{"issue":"2","key":"2022021012531910300_CIT0022","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpeds.2010.02.003","article-title":"Continuous glucose monitoring in newborn babies at risk of hypoglycemia","volume":"157","author":"Harris","year":"2010","journal-title":"J Pediatr."},{"issue":"1","key":"2022021012531910300_CIT0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/archdischild-2017-314137","article-title":"Perspective from the chairs of the British Association of Perinatal Medicine Framework for Practice working group on neonatal hypoglycaemia","volume":"104","author":"Boardman","year":"2019","journal-title":"Arch Dis Child Educ Pract Ed."},{"issue":"4","key":"2022021012531910300_CIT0024","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1932296819831695","article-title":"Impact of CGM on the management of hypoglycemia problems: overview and secondary analysis of the HypoDE study","volume":"13","author":"Hermanns","year":"2019","journal-title":"J Diabetes Sci Technol."},{"issue":"3","key":"2022021012531910300_CIT0025","doi-asserted-by":"crossref","first-page":"151392","DOI":"10.1016\/j.semperi.2021.151392","article-title":"Cost-effectiveness of real time continuous glucose monitoring to target glucose control in preterm infants","volume":"45","author":"Petrou","year":"2021","journal-title":"Semin Perinatol."},{"issue":"4","key":"2022021012531910300_CIT0026","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2352-4642(20)30367-9","article-title":"Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial","volume":"5","author":"Beardsall","year":"2021","journal-title":"Lancet Child Adolesc Health."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab601\/40795509\/dgab601.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/1\/e246\/42493281\/dgab601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/1\/e246\/42493281\/dgab601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:53:45Z","timestamp":1644479625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/1\/e246\/6354421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,18]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab601","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,18]]}}}